← Return to Suzetrigine - a novel drug for pain
DiscussionSuzetrigine - a novel drug for pain
Chronic Pain | Last Active: 11 hours ago | Replies (210)Comment receiving replies
Replies to "It looks to me as if this Journavxn is a "Pie-i-the-Sky" drug that may never live..."
Could be,,,the research on diabetic neuropathy is, I believe in the phase 3 trial...Who knows if it will continue to be funded..The research for a phase 3 trial for lumbar radiculopathy, after a poorly designed phase 2 trial.was meant to proceed I'm sure that funding is in jeopardy, as well. My experience thus far, which clearly means nothing in terms of broader efficacy, was 50mg 2x's a day did nothing discernible. At my pain doctors urging I tried 100mg 2x's a day. I continued taking Celebrex once a day and tylenol arthritis 2x's a day. Adding Journvx made a difference. Having said that there could be unforeseen side effects at this dose....a risk I would take but it is unaffordable.